D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Churchill Downs
CHDN
$5.76B
| $5.08M | 0.01% |
74,020
+16,448
| +29% | +$1.07M |
|
|
SAGE
1677
CALL
DELISTED
Sage Therapeutics
SAGE
| $5.08M | 0.01% |
70,300
| – | – |
|
1678
CALL
Stryker
SYK
$133B
| $5.06M | 0.01% |
24,100
-10,000
| -29% | -$2.08M |
|
1679
Ralph Lauren
RL
$23B
| $5.05M | 0.01% |
43,125
+17,707
| +70% | +$1.87M |
|
1680
PUT
Jazz Pharmaceuticals
JAZZ
$16.2B
| $5.05M | 0.01% |
+33,800
| New | +$4.6M |
|
1681
MasTec
MTZ
$25.6B
| $5.05M | 0.01% |
78,640
-62,625
| -44% | -$4.12M |
|
|
DESP
1682
DELISTED
Despegar.com
DESP
| $5.04M | 0.01% |
374,142
+7,494
| +2% | +$88.6K |
|
1683
PUT
Ventas
VTR
$44.7B
| $5.04M | 0.01% |
+87,200
| New | +$5.48M |
|
1684
Comscore
SCOR
$112M
| $5.03M | 0.01% |
50,875
-18,007
| -26% | -$1.23M |
|
|
CURO
1685
DELISTED
CURO Group Holdings Corp.
CURO
| $5.01M | 0.01% |
411,660
+163,597
| +66% | +$2.19M |
|
1686
Southwest Gas
SWX
$6.54B
| $5.01M | 0.01% |
65,949
+58,614
| +799% | +$4.77M |
|
1687
Warrior Met Coal
HCC
$4.25B
| $5M | 0.01% |
236,446
-97,096
| -29% | -$1.98M |
|
|
UCB
1688
United Community Banks
UCB
$4.23B
| $4.98M | 0.01% |
161,323
-11,424
| -7% | -$345K |
|
1689
CALL
McKesson
MCK
$101B
| $4.98M | 0.01% |
36,000
+9,700
| +37% | +$1.37M |
|
1690
Akebia Therapeutics
AKBA
$362M
| $4.98M | 0.01% |
787,631
+378,588
| +93% | +$1.8M |
|
1691
Manchester United
MANU
$4.04B
| $4.98M | 0.01% |
249,749
+9,446
| +4% | +$163K |
|
|
JBTM
1692
JBT Marel
JBTM
$7.31B
| $4.97M | 0.01% |
44,140
-4,559
| -9% | -$488K |
|
1693
Northern Oil and Gas
NOG
$2.27B
| $4.97M | 0.01% |
212,491
+75,581
| +55% | +$1.5M |
|
|
THR
1694
DELISTED
Thermon Group Holdings
THR
| $4.97M | 0.01% |
185,496
+46,501
| +33% | +$1.17M |
|
1695
Silicon Laboratories
SLAB
$7.15B
| $4.97M | 0.01% |
42,847
+28,935
| +208% | +$3.17M |
|
1696
Modine Manufacturing
MOD
$10.3B
| $4.97M | 0.01% |
645,203
+28,601
| +5% | +$256K |
|
1697
CALL
Goodyear
GT
$2.04B
| $4.96M | 0.01% |
319,100
+200,200
| +168% | +$3.13M |
|
|
OMN
1698
DELISTED
OMNOVA Solutions Inc.
OMN
| $4.96M | 0.01% |
490,976
+3,043
| +0.6% | +$30.7K |
|
|
EIGI
1699
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $4.96M | 0.01% |
1,054,339
+119,639
| +13% | +$492K |
|
1700
Archer Daniels Midland
ADM
$38.9B
| $4.94M | 0.01% |
106,654
-809,585
| -88% | -$34.5M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.